VOLUME 9 (2018)
View Archive »
About The Cover
The cover for issue 6 of Oncotarget features Figure 1, "Galunisertib is a selective inhibitor of TGFβRI (Alk5) and Alk4," from Yingling, et al.
|
|
Table of Contents
Priority Research Papers
|
| Preclinical assessment of galunisertib LY2157299 monohydrate a firstinclass transforming growth factorβ receptor type I inhibitor |
|
https://doi.org/10.18632/oncotarget.23795
|
| 6659-6677 |
Research Papers: Pathology
|
| Interleukin13 peptide vaccine induces protective humoral immunity in murine asthma models |
|
https://doi.org/10.18632/oncotarget.19950
|
| 6678-6690 |
|
| Idiopathic multicentric Castleman’s disease: a clinicopathologic study in comparison with IgG4related disease |
|
https://doi.org/10.18632/oncotarget.24068
|
| 6691-6706 |
|
| Endoplasmic reticulum stress stimulates the release of extracellular vesicles carrying dangerassociated molecular pattern DAMP molecules |
|
https://doi.org/10.18632/oncotarget.24158
|
| 6707-6717 |
Research Papers
|
| Type 2 diabetes epidemic in East Asia: a 35–year systematic trend analysis |
|
https://doi.org/10.18632/oncotarget.22961
|
| 6718-6727 |
|
| Synthetic analysis of associations between IL10 polymorphisms and skin cancer risk |
|
https://doi.org/10.18632/oncotarget.23385
|
| 6728-6736 |
|
| Prognostic significance of Cytokeratin 20positive lymph node vascular endothelial growth factor A mRNA and chromodomain helicase DNA binding protein 4 in pN0 colorectal cancer patients |
|
https://doi.org/10.18632/oncotarget.23424
|
| 6737-6751 |
|
| Plasma YKL40 as a biomarker for bevacizumab efficacy in patients with newly diagnosed glioblastoma in the phase 3 randomized AVAglio trial |
|
https://doi.org/10.18632/oncotarget.22886
|
| 6752-6762 |
|
| Distinct pattern of cerebral blood flow alterations specific to schizophrenics experiencing auditory verbal hallucinations with and without insight: a pilot study |
|
https://doi.org/10.18632/oncotarget.23631
|
| 6763-6770 |
|
| Kanglaite inhibits EMT caused by TNFα via NFκΒ inhibition in colorectal cancer cells |
|
https://doi.org/10.18632/oncotarget.23645
|
| 6771-6779 |
|
| Inferring modes of evolution from colorectal cancer with residual polyp of origin |
|
https://doi.org/10.18632/oncotarget.23687
|
| 6780-6792 |
|
| The SNPs in premiRNA are related to the response of capecitabinebased therapy in advanced colon cancer patients |
|
https://doi.org/10.18632/oncotarget.23190
|
| 6793-6799 |
|
| Identification of the potential crucial genes in invasive ductal carcinoma using bioinformatics analysis |
|
https://doi.org/10.18632/oncotarget.23239
|
| 6800-6813 |
|
| Tolllike receptor 2 induces adenosine receptor A2a and promotes human squamous carcinoma cell growth via extracellular signal regulated kinases ½ |
|
https://doi.org/10.18632/oncotarget.23784
|
| 6814-6829 |
|
| Characterization of aptamermediated gene delivery system for liver cancer therapy |
|
https://doi.org/10.18632/oncotarget.23564
|
| 6830-6840 |
|
| Determinants of variability of five programmed death ligand1 immunohistochemistry assays in nonsmall cell lung cancer samples |
|
https://doi.org/10.18632/oncotarget.23827
|
| 6841-6851 |
|
| Effects of STC1 overexpression on tumorigenicity and metabolism of hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.23566
|
| 6852-6861 |
|
| A robust gene expressionbased prognostic risk score predicts overall survival of lung adenocarcinoma patients |
|
https://doi.org/10.18632/oncotarget.23490
|
| 6862-6871 |
|
| Dynamic changes in CD44vpositive cells after preoperative antiHER2 therapy and its correlation with pathologic complete response in HER2positive breast cancer |
|
https://doi.org/10.18632/oncotarget.23914
|
| 6872-6882 |
|
| Temozolomide sirolimus and chloroquine is a new therapeutic combination that synergizes to disrupt lysosomal function and cholesterol homeostasis in GBM cells |
|
https://doi.org/10.18632/oncotarget.23855
|
| 6883-6896 |
|
| SMAD4independent activation of TGFβ signaling by MUC1 in a human pancreatic cancer cell line |
|
https://doi.org/10.18632/oncotarget.23966
|
| 6897-6910 |
|
| Socioeconomic status is inversely associated with esophageal squamous cell carcinoma risk: results from a populationbased casecontrol study in China |
|
https://doi.org/10.18632/oncotarget.24003
|
| 6911-6923 |
|
| ZB716 a steroidal selective estrogen receptor degrader SERD is orally efficacious in blocking tumor growth in mouse xenograft models |
|
https://doi.org/10.18632/oncotarget.24023
|
| 6924-6937 |
|
| Spiclomazine displays a preferential antitumor activity in mutant KRasdriven pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.24025
|
| 6938-6951 |
|
| In vitro in vivo and ex vivo demonstration of the antitumoral role of hypocretin1/orexinA and almorexant in pancreatic ductal adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.24084
|
| 6952-6967 |
|
| The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junction |
|
https://doi.org/10.18632/oncotarget.24087
|
| 6968-6976 |
|
| Distinct expression of CDCA3 CDCA5 and CDCA8 leads to shorter relapse free survival in breast cancer patient |
|
https://doi.org/10.18632/oncotarget.24059
|
| 6977-6992 |
|
| A comparative study of PDL1 immunohistochemical assays with four reliable antibodies in thymic carcinoma |
|
https://doi.org/10.18632/oncotarget.24075
|
| 6993-7009 |
|
| The prognostic efficacy of cellfree DNA hypermethylation in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.24097
|
| 7010-7022 |
|
| Metformin inhibits TGFβ1induced epithelialtomesenchymal transitionlike process and stemlike properties in GBM via AKT/mTOR/ZEB1 pathway |
|
https://doi.org/10.18632/oncotarget.23317
|
| 7023-7035 |
|
| Challenges in using liquid biopsies for gene expression profiling |
|
https://doi.org/10.18632/oncotarget.24140
|
| 7036-7053 |
|
| Identification and characterisation of NANOG+/ OCT4high/SOX2+ doxorubicinresistant stemlike cells from transformed trophoblastic cell lines |
|
https://doi.org/10.18632/oncotarget.24151
|
| 7054-7065 |
|
| Genetic polymorphisms in HLADP and STAT4 are associated with IgA nephropathy in a Southwest Chinese population |
|
https://doi.org/10.18632/oncotarget.23829
|
| 7066-7074 |
|
| Reverting iodine avidity of radioactiveiodine refractory thyroid cancer with a new tyrosine kinase inhibitor K9050266 excavated by highthroughput NIS sodium iodide symporter enhancer screening platform using dual reporter gene system |
|
https://doi.org/10.18632/oncotarget.24159
|
| 7075-7087 |
|
| Diffusionweighted imaging in identifying breast cancer pathological response to neoadjuvant chemotherapy: A metaanalysis |
|
https://doi.org/10.18632/oncotarget.23195
|
| 7088-7100 |
|
| Metaanalysis of a 10plex urinebased biomarker assay for the detection of bladder cancer |
|
https://doi.org/10.18632/oncotarget.23872
|
| 7101-7111 |
|
| Efficacy and safety of thrombopoietin receptor agonists in children with chronic immune thrombocytopenia: a metaanalysis |
|
https://doi.org/10.18632/oncotarget.23487
|
| 7112-7125 |
|
| Milk/dairy products consumption and gastric cancer: an update metaanalysis of epidemiological studies |
|
https://doi.org/10.18632/oncotarget.23496
|
| 7126-7135 |
|
| Vitamin D receptor Taq I polymorphism and the risk of prostate cancer: a metaanalysis |
|
https://doi.org/10.18632/oncotarget.23606
|
| 7136-7147 |
|
| Gemcitabinebased chemotherapy as a viable option for treatment of advanced breast cancer patients: a metaanalysis and literature review |
|
https://doi.org/10.18632/oncotarget.23426
|
| 7148-7161 |
Clinical Research Papers
|
| Pharmacokinetic properties of radiolabeled mutant Interleukin2v: a PET imaging study |
|
https://doi.org/10.18632/oncotarget.23852
|
| 7162-7174 |
|
| Apatinib as a third or further line treatment in patients with advanced NSCLC harboring wildtype EGFR |
|
https://doi.org/10.18632/oncotarget.23612
|
| 7175-7181 |
|
| A liquid biopsy for bronchopulmonary/lung carcinoid diagnosis |
|
https://doi.org/10.18632/oncotarget.23820
|
| 7182-7196 |
|
| The outcomes and prognostic factors of acute respiratory failure in the patients 90 years old and over |
|
https://doi.org/10.18632/oncotarget.24051
|
| 7197-7203 |
Reviews
|
| Inflammatory responses and inflammationassociated diseases in organs |
|
https://doi.org/10.18632/oncotarget.23208
|
| 7204-7218 |
|
| New extracellular factors in glioblastoma multiforme development: neurotensin growth differentiation factor15 sphingosine1phosphate and cytomegalovirus infection |
|
https://doi.org/10.18632/oncotarget.24102
|
| 7219-7270 |
Corrections
|
| Correction: Cotargeting translation and proteasome rapidly kills colon cancer cells with mutant RAS/RAF via ER stress |
|
https://doi.org/10.18632/oncotarget.24288
|
| 7271-7271 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
